Business Description
Atlassian Corporation, through its subsidiaries, designs, develops, licenses, and maintains various software products worldwide. Its product portfolio includes Jira Software and Jira Work Management, a project management system that connects technical and business teams so they can better plan, organize, track and manage their work and projects; Confluence, a connected workspace that organizes knowledge across all teams to move work forward; and Trello, a collaboration and organization product that captures and adds structure to fluid and fast-forming work for teams. The company also offers Jira Service Management, an intuitive and flexible service desk product for creating and managing service experiences for various service team providers, such as IT, legal, and HR teams; and Jira Align, an Atlassian's enterprise agility solution designed to help businesses to adapt and respond dynamic business conditions with a focus on value-creation. In addition, it provides Bitbucket, an enterprise-ready Git solution that enables professional dev teams to manage, collaborate, and deploy quality code; Atlassian Access, an enterprise-wide product for enhanced security and centralized administration that works across every Atlassian cloud product; and Jira Product, a prioritization and road mapping tool. Further, the company's portfolio includes Atlas, a teamwork directory; Bamboo, a continuous delivery pipeline; Crowd, a single sign-on; Crucible, a collaborative code review; Fisheye, a search, track, and visualize code change software; and Compass, a developer experience platform. Additionally, it offers Opsgenie, an on-call and alert management software; Sourcetree, a free git client for windows and mac; Statuspage that communicates real-time status to users; Beacon, an intelligent threat detection software; and Atlassian Access that enhance data security and governance for Atlassian Cloud products. The company was founded in 2002 and is headquartered in Sydney, Australia.
Business History
Price Overview
Last updated: May 11, 2026 1:53pm (just now)Price History (1 Year)
Revenue & Net Income Trend
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
EPS (Diluted): -0.98
Total Equity: $1.35B
Shares: 261,787,000
Total Debt: $987.68M
Cash: $2.51B
EBITDA: $24.03M
Total Debt: $987.68M
Cash: $2.51B
Revenue: $5.22B
Revenue: $5.22B
Revenue: $5.22B
Total Equity: $1.35B
Tax Rate: -159.6%
Equity: $1.35B
Total Debt: $987.68M
Cash: $2.51B
Current Liabilities: $3.18B
Long-Term Debt: $987.68M
Total Debt: $987.68M
Total Equity: $1.35B
Shares: 261,787,000
Shares: 261,787,000
CapEx: -$44.85M
Shares: 261,787,000
Stock Price: $85.37
Net Income: -$256.69M
Industry Benchmarks
Deep Analysis
Pre-flight intelligence scans the company first, then routes to the right analytical methods.
Income Statement (Annual)
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $2.1B | $2.8B | $3.5B | $4.4B | $5.2B |
| Cost of Revenue | $346.7M | $452.9M | $633.8M | $803.5M | $894.9M |
| Gross Profit | $1.7B | $2.3B | $2.9B | $3.6B | $4.3B |
| Operating Expenses | $1.7B | $2.3B | $3.2B | $3.7B | $4.5B |
| Operating Income | $67.6M | $70.1M | -$345.2M | -$117.1M | -$130.4M |
| Net Income | -$696.3M | -$519.5M | -$486.8M | -$300.5M | -$256.7M |
| EBITDA | -$419.1M | -$377.7M | -$220.1M | $27.4M | $24.0M |
| EPS | $-2.79 | $-2.05 | $-1.90 | $-1.16 | $-0.98 |
| EPS (Diluted) | — | — | — | — | — |
Balance Sheet (Annual)
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $919.2M | $1.4B | $2.1B | $2.2B | $2.5B |
| Total Current Assets | $1.6B | $1.9B | $2.7B | $3.1B | $3.9B |
| Total Assets | $2.9B | $3.3B | $4.1B | $5.2B | $6.0B |
| Current Liabilities | $2.3B | $1.6B | $2.0B | $2.6B | $3.2B |
| Long-Term Debt | $0 | $999.4M | $962.1M | $985.9M | $987.7M |
| Total Liabilities | $2.7B | $3.0B | $3.5B | $4.2B | $4.7B |
| Total Equity | $294.9M | $327.4M | $654.7M | $1.0B | $1.3B |
| Retained Earnings | -$1.8B | -$1.9B | -$2.5B | -$3.2B | -$4.2B |
Cash Flow (Annual)
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $834.8M | $821.0M | $868.1M | $1.4B | $1.5B |
| Capital Expenditure | -$31.5M | -$70.6M | -$25.8M | -$33.1M | -$44.9M |
| Free Cash Flow | $803.3M | $750.5M | $842.3M | $1.4B | $1.4B |
| Acquisitions (net) | -$91.6M | -$12.4M | -$5.8M | -$847.8M | -$14.2M |
| Debt Repayment | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — |
| Stock Buybacks | $0 | $0 | -$150.0M | -$395.3M | -$779.4M |
| Net Change in Cash | -$560.7M | $466.0M | $717.2M | $74.2M | $335.6M |
Analyst Estimates (Annual)
| Metric | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|
| Revenue |
$7.5B $7.3B – $7.6B
|
$8.7B $8.7B – $8.7B
|
$10.2B $9.9B – $10.4B
|
$11.4B $11.0B – $11.6B
|
| EBITDA |
$1.7B $1.7B – $1.7B
|
$2.0B $2.0B – $2.0B
|
$2.3B $2.2B – $2.4B
|
$2.6B $2.5B – $2.6B
|
| Net Income |
$1.6B $1.5B – $1.8B
|
$2.3B $1.2B – $3.5B
|
$2.3B $2.2B – $2.3B
|
$2.8B $2.7B – $2.8B
|
| EPS | — | — | — | — |
Growth Trends (YoY %)
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | +34.2% | +26.1% | +23.3% | +19.7% |
| Gross Profit Growth | +34.9% | +23.4% | +22.6% | +21.5% |
| Operating Income Growth | +3.6% | -592.6% | +66.1% | -11.4% |
| Net Income Growth | +25.4% | +6.3% | +38.3% | +14.6% |
| EBITDA Growth | +9.9% | +41.7% | +112.5% | -12.3% |
Insider Trading (Recent)
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-04-23 | DUFFY BRIAN | A-Award | 121,512.00 | $0.00 | $0 |
| 2026-04-02 | CHUONG JAMES | A-Award | 297,030.00 | $0.00 | $0 |
| 2026-03-30 | CHUONG JAMES | 0.00 | $0.00 | $0 | |
| 2026-02-19 | LIU GENE | S-Sale | 28.00 | $80.57 | $2,256 |
| 2026-02-19 | LIU GENE | S-Sale | 8.00 | $82.60 | $661 |
| 2026-02-19 | LIU GENE | S-Sale | 28.00 | $81.63 | $2,286 |
| 2026-02-19 | LIU GENE | S-Sale | 2.00 | $83.55 | $167 |
| 2026-02-19 | DUFFY BRIAN | S-Sale | 151.00 | $82.60 | $12,473 |
| 2026-02-19 | DUFFY BRIAN | S-Sale | 525.00 | $81.63 | $42,858 |
| 2026-02-19 | DUFFY BRIAN | S-Sale | 30.00 | $83.55 | $2,507 |
| 2026-02-19 | DUFFY BRIAN | S-Sale | 516.00 | $80.57 | $41,572 |
| 2026-02-19 | RAJAN RAJEEV BASHYAM | S-Sale | 1,297.00 | $80.57 | $104,494 |
| 2026-02-19 | RAJAN RAJEEV BASHYAM | S-Sale | 379.00 | $82.60 | $31,307 |
| 2026-02-19 | RAJAN RAJEEV BASHYAM | S-Sale | 1,321.00 | $81.63 | $107,840 |
| 2026-02-19 | RAJAN RAJEEV BASHYAM | S-Sale | 75.00 | $83.55 | $6,266 |
| 2026-02-19 | BINZ JOSEPH LEO | S-Sale | 204.00 | $82.60 | $16,851 |
| 2026-02-19 | BINZ JOSEPH LEO | S-Sale | 711.00 | $81.63 | $58,042 |
| 2026-02-19 | BINZ JOSEPH LEO | S-Sale | 40.00 | $83.55 | $3,342 |
| 2026-02-19 | BINZ JOSEPH LEO | S-Sale | 698.00 | $80.57 | $56,235 |
| 2026-02-17 | LIU GENE | S-Sale | 29.00 | $83.78 | $2,430 |